DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

NCT07142278 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Alzheimer Disease (AD)
Preclinical Alzheimer's Disease

Interventions

BIOLOGICAL: DUVAX 200 µg
BIOLOGICAL: DUVAX 400 µg
BIOLOGICAL: Placebo (Adjuvant only)

Sponsor

Nuravax, Inc.

Collaborators

[object Object]
[object Object]